Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.
Pluton Biosciences has raised $16.5M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
Pluton Biosciences's investors include RA Capital Management, Wing Venture Capital, Better Ventures, Illumina Ventures, Wollemi.
Pluton Biosciences is headquartered in Saint Louis, United States.
Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.
Pluton Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pluton Biosciences — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/pluton-biosciences. Accessed August 14, 2026.
VCBacked. (2023). Pluton Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pluton-biosciences
{{cite web |title=Pluton Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/pluton-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated